Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis

Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial

(2023) Zoe D Draelos et al.   BRITISH JOURNAL OF DERMATOLOGY

Perspective insights of small molecules, phytoconstituents and biologics in the management of psoriasis: A focus on targeting major inflammatory cytokine pathways

(2023) Husna Kadagothy et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)

(2023) Mette Gyldenløve et al.   The Lancet Regional Health Europe

Current and emerging prospects in the psoriatic treatment

(2023) Rutuja Vilas Nikam et al.   International Immunopharmacology

Oral roflumilast as a therapeutic option for psoriasis, what role does it have? Case report and literature review

(2023) Javier Gimeno Castillo et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors

(2023) Lana Schmidt et al.   Dermatology and Therapy

Rapid improvement of idiopathic aphthous ulcers with oral roflumilast therapy

(2022) Mette Gyldenløve et al.   BRITISH JOURNAL OF DERMATOLOGY

Advances in the pathogenesis of psoriasis: from keratinocyte perspective

(2022) Xue Zhou et al.   Cell Death & Disease

Considerable improvement in hidradenitis suppurativa with oral roflumilast therapy

(2022) Hans Christian Ring et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatments for psoriasis: A journey from classical to advanced therapies. How far have we reached?

(2022) Gangadhar Hari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Roflumilast for Chronic Plaque Psoriasis

(2022) Kelly M. Cordoro   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis

(2022) Mark G. Lebwohl et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long‐term clearance of severe plaque psoriasis with oral roflumilast

(2022) Mette Gyldenløve et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies

(2022) Archie W. Thurston et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial

(2022) Linda Stein Gold et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

A Review of Topical Roflumilast for the Treatment of Plaque Psoriasis

(2022) Jessica N. Pixley et al.   ANNALS OF PHARMACOTHERAPY

Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities

(2021) Alan Menter et al.   Dermatology and Therapy

JOINT AAD-NPF GUIDELINES OF CARE FOR THE MANAGEMENT OF PSORIASIS WITH SYSTEMIC NON-BIOLOGICAL THERAPIES

(2020) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

(2020) Craig A. Elmets et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Trial of Roflumilast Cream for Chronic Plaque Psoriasis

(2020) Mark G. Lebwohl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study

(2020) Kim Papp et al.   Journal of Drugs in Dermatology

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

(2019) Craig A. Elmets et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

(2019) Alan Menter et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy

(2019) Craig A. Elmets et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition

(2018) Emma Guttman‐Yassky et al.   EXPERIMENTAL DERMATOLOGY

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

(2015) Kim Papp et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Psoriasis

(2015) Wolf-Henning Boehncke et al.   LANCET

Living with Psoriasis: Prevalence of Shame, Anger, Worry, and Problems in Daily Activities and Social Life

(2013) F Sampogna et al.   ACTA DERMATO-VENEREOLOGICA

Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States

(2013) April W. Armstrong et al.   JAMA Dermatology

Excessive Body Weight and Smoking Associates with a High Risk of Onset of Plaque Psoriasis

(2009) K Wolk et al.   ACTA DERMATO-VENEREOLOGICA

Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population-based study

(2009) Floranne C. Wilson et al.   ARTHRITIS AND RHEUMATISM

Cyclic AMP

(2008) Carlos H. Serezani et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY